American Well Corp
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNA TURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| American Well Corporation | ||
| Date: February 12, 2026 | By: | /s/ Ido Schoenberg, MD |
|---|---|---|
| Ido Schoenberg | ||
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Ido Schoenberg, MD | Chief Executive Officer (principal executive officer) | February 12, 2026 |
| Ido Schoenberg | ||
| /s/ Mark Hirschhorn | Chief Financial Officer(principal financial officer) | February 12, 2026 |
| Mark Hirschhorn | ||
| /s/ Paul McNeice | Chief Accounting Officer(principal accounting officer) | February 12, 2026 |
| Paul McNeice | ||
| /s/ Roy Schoenberg, MD, MPH | Director | February 12, 2026 |
| Roy Schoenberg | ||
| /s/ Rivka Goldwasser | Director | February 12, 2026 |
| Rivka Goldwasser | ||
| /s/ Stephen Schlegel | Director | February 12, 2026 |
| Stephen Schlegel | ||
| /s/ Dr. Peter Slavin | Director | February 12, 2026 |
| Dr. Peter Slavin | ||
| /s/ Derek Ross | Director | February 12, 2026 |
| Derek Ross | ||
| /s/ Dr. Toby Cosgrove | Director | February 12, 2026 |
| Toby Cosgrove | ||
| /s/ Rob Webb | Director | February 12, 2026 |
| Rob Webb | ||
| /s/ Deborah Jackson | Director | February 12, 2026 |
| Deborah Jackson | ||
Index to consolidated Financial Statements
| Page(s) | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets | F-4 |
| Consolidated Statements of Operations and Comprehensive Loss | F-5 |
| Consolidated Statements of Stockholders’ Equity | F-6 |
| Consolidated Statements of Cash Flows | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.